Sweden / United States / Canada / United Kingdom / /
Currency
USD / / / /
IndustryTerm
plasma products / treatment products / blood products / Treatment for Hemophilia / study protocol / healthcare delivery / Hemophilia Care / healthcare reform / particular product / healthcare systems / healthcare legislation / Therapies for Rare Bleeding Disorders / healthcare decision-makers / particular treatment products / hemophilia treatment / treatment of Alzheimer’s disease / biosimilar product / treatment for people with inherited bleeding disorders / therapies for hemophilia / biosimilar products / manufacturing / wfh@wfh.org Internet / health technology assessments / orphan drug products / /
MedicalCondition
variant Creutzfeldt Jakob Disease / Van Creveld hemophilia / rare diseases / severe hemophilia A. The / inherited bleeding disorders / Hemophilia / orphan diseases / rare / congenital bleeding disorder / Alzheimer’s disease / hemophilia A / disease / Rare Bleeding Disorders / Severe Hemophilia / every disease / reported hemophilia A / pain / rare disorders / infection / hemarthrosis / severe hemophilia A / Disorders / /
Movie
To Be or Not to Be / /
Organization
National Hemophilia Foundation / International Unit / Communications Department / Public Health Agency of Canada / United Kingdom Haemophilia Centre Doctors’ Organisation / Plasma Protein Therapeutics Association / World Federation of Hemophilia / Public Health Agency of Canada Canadian Blood Services Héma-Québec Ministère / U.S. Congress / World Federation of Hemophilia Additional / Quebec Ministry of International Relations / European Commission / National Organization for Rare Disorders / FDA / Québec Ministry of International Relations / Ministry of Health / /
Person
Johanna Gray / Jeffrey Stonebraker / Adam Hutchings / Victor Blanchette / Albert Farrugia / Alok Srivastava / Jay Greissing / Chris James / George Adams / David Page / Bruce Evatt / Patrick Robert / Mike Soucie / Dorthe Viuff / Deborah Brown / Mahony / Michael Lauer / Mike Makris / Diane Edquist Dorman / Mark W. Skinner / / /
Position
president / Risk Assessments General / Executive / contents Executive / /
ProvinceOrState
Quebec / /
Technology
antibodies / MRI / Prions / 57 Fusion Protein Technology / severe hemophilia A. The study protocol / /
The World Federation of Hemophilia’s Sixth Global Forum on the Safety and Supply of Treatment Products for Bleeding Disorders